Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Reunion Neuroscience
  6. News
  7. Summary
    REUN   CA76134G1037

REUNION NEUROSCIENCE

(REUN)
  Report
Delayed Toronto Stock Exchange  -  03:59 2022-09-29 pm EDT
2.000 CAD   -3.85%
09/29Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting
AQ
09/29Transcript : Field Trip Health Ltd. - Shareholder/Analyst Call
CI
09/28Reunion Neuroscience Appointing Greg Mayes as President and Chief Executive Officer
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Field Trip Health Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2022

08/15/2022 | 07:47pm EDT

Field Trip Health Ltd. reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported net loss was CAD 13.46 million compared to CAD 12.53 million a year ago. Basic loss per share from continuing operations was CAD 0.45 compared to CAD 0.3 a year ago.

Basic loss per share was CAD 1.15 compared to CAD 1.1 a year ago.


© S&P Capital IQ 2022
All news about REUNION NEUROSCIENCE
09/29Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder M..
AQ
09/29Transcript : Field Trip Health Ltd. - Shareholder/Analyst Call
CI
09/28Reunion Neuroscience Appointing Greg Mayes as President and Chief Executive Officer
MT
09/28Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer
AQ
09/28Reunion Neuroscience Inc. Appoints Greg Mayes as President
CI
09/28Reunion Neuroscience Inc. Appoints Greg Mayes as Chief Executive Officer
CI
09/19US Futures Begin the Week Lower Ahead of Fed Meeting
MT
09/19Top Premarket Gainers
MT
09/19Reunion Neuroscience Inc.(TSX:REUN) dropped from S&P Globa..
CI
09/08Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences
AQ
More news
Analyst Recommendations on REUNION NEUROSCIENCE
More recommendations
Financials
Sales 2023 0,91 M 0,67 M 0,67 M
Net income 2023 -29,2 M -21,3 M -21,3 M
Net Debt 2023 - - -
P/E ratio 2023 -1,68x
Yield 2023 -
Capitalization 23,3 M 17,0 M 17,0 M
Capi. / Sales 2023 25,5x
Capi. / Sales 2024 -
Nbr of Employees 194
Free-Float 71,2%
Chart REUNION NEUROSCIENCE
Duration : Period :
Reunion Neuroscience Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REUNION NEUROSCIENCE
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,00 CAD
Average target price 52,50 CAD
Spread / Average Target 2 525%
EPS Revisions
Sector and Competitors
1st jan.Capi. (M$)
REUNION NEUROSCIENCE-86.93%17
JOHNSON & JOHNSON-3.82%432 579
ELI LILLY AND COMPANY21.06%313 567
ROCHE HOLDING AG-15.52%269 089
ABBVIE INC.5.41%252 343
PFIZER, INC.-25.22%247 841